All In Biotech

Drug Trial Radar · NCT00493870

TAC Versus TC for Adjuvant Breast Cancer

Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients

Last checked: Nov 20, 2026Latest source record: Mar 2, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,961 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,961

Actual

Start

May 29, 2007

Primary completion

May 31, 2015

Study completion Mar 30, 2020

Sponsor

Lead sponsor
US Oncology ResearchIndustry
Sponsor type
Industry
Collaborators
Sanofi
First posted
Jun 28, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research study is to find out what effects (good and bad) TC or TAC has on early stage HER2- breast cancer.

Conditions

  • Breast Cancer

Interventions

  • DocetaxelDrug

    Docetaxel 75 mg/m2 IV over 1 hour on Day 1 followed by cyclophosphamide

  • DoxorubicinDrug

    • Doxorubicin 50 mg/m2 IV push over 5-15 minutes via sidearm through a running IV line on Day 1, followed by cyclophosphamide 500 mg/m2 IV over 15-30 minutes on Day 1, followed by docetaxel 75 mg/m2 IV over 1 hour on Day 1. Administer pegfilgrastim 6 mg SC on Day 2 (or filgrastim 5 mcg/kg SC per standard of care).

  • CyclophosphamideDrug

    600 mg/m2 IV over 15-30 minutes on Day 1.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 3-year Invasive Disease-free Survival (IDFS) Among Analyzed ITT PatientsTime frame: 3 years from randomization into study
  2. 3-year Invasive Disease-free Survival (IDFS) Among Per-protocol PatientsTime frame: 3 years from randomization into study

Locations

95 sites in 1 country. Site status is shown where the registry gives one.

  • Birmingham Hematology and Oncology

    Birmingham, Alabama

  • Hematology Oncology Associates

    Phoenix, Arizona

  • Northern AZ Hematology Oncology Associates-AOA

    Sedona, Arizona

  • Arizona Oncology Associates DBA HOPE

    Tucson, Arizona

  • Central Hematology Oncology Medical Group, Inc.

    Alhambra, California

  • Comprehensive Blood and Cancer Center

    Bakersfield, California

  • St. Jude Hertiage Medical Group

    Fullerton, California

  • Wilshire Oncology Medical Group

    La Verne, California

  • Antelope Valley Cancer Center

    Lancaster, California

  • Pacific Shores Medical Group

    Long Beach, California

  • University of California-Los Angeles

    Los Angeles, California

  • North Valley Hematology/Oncology Medical Group

    Northridge, California

  • Ventura County Hematology-Oncology Specialist

    Oxnard, California

  • SAMSUM Clinic

    Santa Barbara, California

  • Santa Barabra Hematology Oncology Medical Group, Inc.

    Santa Barbara, California

  • Central Coast Medical Oncology Corporation

    Santa Maria, California

  • Rocky Mountain Cancer Center-Rose

    Denver, Colorado

  • Flordia Cancer Specialist

    Fort Myers, Florida

  • Melbourne Internal Medicine Associates

    Melbourne, Florida

  • Advanced Medical Specialist

    Miami, Florida

  • Florida Cancer Institute

    New Port Richey, Florida

  • Ocala Oncology Center

    Ocala, Florida

  • Cancer Centers of Florida, P.A.

    Ocoee, Florida

  • Suburban Hematology-Oncology Associates, PC

    Lawrenceville, Georgia

  • Northwest Georgia Oncology Centers, PC

    Marietta, Georgia

  • Hematology Oncology Associates of IL

    Chicago, Illinois

  • Cancer Care & Hematology Specialists of Chicagoland

    Niles, Illinois

  • Central Indiana Cancer Centers

    Indianapolis, Indiana

  • Hope Center

    Terre Haute, Indiana

  • Kansas City Cancer Centers-Southwest

    Overland Park, Kansas

  • Maryland Oncology Hematology, P.A.

    Columbia, Maryland

  • Alliance Hematology Oncology PA

    Westminster, Maryland

  • Minnesota Oncology Hematology, P.A.

    Minneapolis, Minnesota

  • Missouri Cancer Associates

    Columbia, Missouri

  • Arch Medical Services, Inc.

    St Louis, Missouri

  • Comprehensive Cancer Center of Nevada

    Henderson, Nevada

  • Hematology-Oncology Associates of NNJ, P.A.

    Morristown, New Jersey

  • Southern New Mexico Cancer Center

    Las Cruces, New Mexico

  • New Mexico Cancer Care Associates

    Santa Fe, New Mexico

  • New York Oncology Hematology, P.C.

    Albany, New York

Showing 40 of 95 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.